{"data":[{"accessionNo":"0001950047-26-007380","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"GREG ZANTE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":21217,"aggregateMarketValue":710141.48,"unitsOutstanding":116105643,"approxSaleDate":"2026-07-29","exchange":"NASDAQ","filedAt":"2026-07-29"},{"accessionNo":"0001950047-26-007376","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"MARIANNA MANCINI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":18217,"aggregateMarketValue":609635.55,"unitsOutstanding":116105643,"approxSaleDate":"2026-07-29","exchange":"NASDAQ","filedAt":"2026-07-29"},{"accessionNo":"0001950047-26-007394","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"BRIAN LIAN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":148517,"aggregateMarketValue":4947888.41,"unitsOutstanding":116105643,"approxSaleDate":"2026-07-29","exchange":"NASDAQ","filedAt":"2026-07-29"},{"accessionNo":"0001950047-26-000105","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"GREG ZANTE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":57661,"aggregateMarketValue":1901469.5,"unitsOutstanding":113036344,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05"},{"accessionNo":"0001950047-26-000106","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"MARIANNA MANCINI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":57661,"aggregateMarketValue":1901406.07,"unitsOutstanding":113036344,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05"},{"accessionNo":"0001950047-26-000104","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"BRIAN LIAN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":233409,"aggregateMarketValue":7692133.64,"unitsOutstanding":113036344,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05"},{"accessionNo":"0001950047-26-000086","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"MATTHEW W. FOEHR","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":16000,"aggregateMarketValue":561694.4,"unitsOutstanding":113036344,"approxSaleDate":"2026-01-02","exchange":"NASDAQ","filedAt":"2026-01-02"},{"accessionNo":"0001950047-25-008235","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"GREG ZANTE","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6185,"aggregateMarketValue":216530.67,"unitsOutstanding":113036344,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28"},{"accessionNo":"0001950047-25-008234","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"MARIANNA MANCINI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6185,"aggregateMarketValue":216491.7,"unitsOutstanding":113036344,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28"},{"accessionNo":"0001950047-25-008233","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"BRIAN LIAN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":38989,"aggregateMarketValue":1364923.01,"unitsOutstanding":113036344,"approxSaleDate":"2025-10-28","exchange":"NASDAQ","filedAt":"2025-10-28"},{"accessionNo":"0001950047-25-008201","issuerCik":"0001607678","issuerName":"VIKING THERAPEUTICS, INC.","ticker":"VKTX","personName":"CHARLES A ROWLAND JR.","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":60000,"aggregateMarketValue":2134278,"unitsOutstanding":113036344,"approxSaleDate":"2025-10-27","exchange":"NASDAQ","filedAt":"2025-10-27"}],"updatedAt":"2026-10-13T13:02:17.991Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}